Findings
In this randomized clinical trial of 392 Black adults who smoke daily, adapting individuals to varenicline and/or bupropion in combination with a nicotine patch after failure of nicotine patch monotherapy did not significantly improve abstinence rates relative to standard of care treatment with nicotine patch (17.4% vs 11.7%).